Akut mieloid leukémia (AML): vizsgálatok itt: Kína
226 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleVMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
- Where
- Tianjin
- Életkor
- 18 év to 65 év
- People
- 30
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06447090 - 3. fázisNot yet taking people in KínaCompare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR
- Where
- Shanghai
- Életkor
- 16 év to 65 év
- People
- 220
- Run by
- Ruijin Hospital
See details and how to joinNCT06297772 - 2. fázisTaking peopleStudy of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
- Where
- Suzhou
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06394011 - 1/2. fázisNot yet taking people in KínaA Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 180
- Run by
- Akeso
See details and how to joinNCT06387420 - 1/2. fázisTaking peopleTGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06206174 - 3. fázisTaking peopleMA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Huanggang, Jingzhou, Shiyan, Taiyuan, Wuhan, Wuxi, Xianning, Xiaogan, Yichang, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 154
- Run by
- Zhongnan Hospital
See details and how to joinNCT06345365 - No phaseTaking peopleA Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 78
- Run by
- Ruijin Hospital
See details and how to joinNCT06329999 - No phaseTaking peopleClinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
- Where
- Huai'an
- Életkor
- 18 év to 60 év
- People
- 34
- Run by
- Huai'an First People's Hospital
See details and how to joinNCT06328179 - No phaseTaking peopleThe Maintenance Treatment of "ITIVA" in AML Patients
- Where
- Zhengzhou
- Életkor
- 14 év and over
- People
- 130
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06256627 - No phaseTaking peopleClinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
- Where
- Nanjing
- Életkor
- 18 év to 60 év
- People
- 54
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06232694 - 1/2. fázisTaking peopleAdministration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
- Where
- Xuzhou
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Xuzhou Medical University
See details and how to joinNCT06125652 - No phaseTaking peopleA Study of Chidamide With AZA in MRD Positive AML After Transplant
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 60
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06066905 - No phaseNot yet taking people in KínaA Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
- Where
- Guanzhou
- Életkor
- 14 év to 65 év
- People
- 137
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT05875649 - No phaseTaking peopleClinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
- Where
- Nanjing
- Életkor
- 60 év to 85 év
- People
- 100
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05909293 - 2/3. fázisTaking peopleVenetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
- Where
- Suzhou
- Életkor
- 18 év to 60 év
- People
- 60
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05805098 - 2. fázisTaking peopleA Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
- Where
- Ch’ang-ch’un, Changzhou, Chengdu, Ha’erbin, Hefei, Jiaxing, Lanzhou, Ningbo, Shanghai, Shenyang, Shijia Zhuang, Ürümqi, Wuhu, Xi'an, Yangzhou, Yixing
- Életkor
- 18 év and over
- People
- 58
- Run by
- Shanghai Tong Ren Hospital
See details and how to joinNCT05736965 - 2. fázisTaking peopleAdaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 58
- Run by
- Shanghai Tong Ren Hospital
See details and how to joinNCT05736978 - 1/2. fázisTaking peopleChidamide Prevents Recurrence of High-risk AML After Allo-HSCT
- Where
- Chengdu
- Életkor
- 18 év to 65 év
- People
- 77
- Run by
- Sichuan University
See details and how to joinNCT05682755 - 1/2. fázisTaking peopleUnrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05584761 - 2. fázisTaking peopleOlverembatinib for FGFR1-rearranged Neoplasms
- Where
- Suzhou
- People
- 20
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05521204 - 2/3. fázisTaking peopleAZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
- Where
- Suzhou
- Életkor
- 18 év to 64 év
- People
- 124
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05404906 - 1. fázisTaking peopleAnti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT05445011 - 1/2. fázisTaking peopleSKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Chengdu
- Életkor
- 18 év to 59 év
- People
- 58
- Run by
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
See details and how to joinNCT05445154 - Korai 1. fázisTaking peopleCD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
- Where
- Hangzhou
- People
- 108
- Run by
- Zhejiang University
See details and how to joinNCT04662294 - Korai 1. fázisNot yet taking people in KínaNKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
- Where
- Hangzhou
- Életkor
- 3 év to 70 év
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT04658004